(Q55147643)

22 June 2018

title

Natural killer T cell ligand alpha-galactosylceramide inhibited lymph node metastasis of highly metastatic melanoma cells. (English)

1 reference

22 June 2018

0 references

1 reference

lymph node metastasis

1 reference

M Nakui

1

1 reference

22 June 2018

K Iwakabe

2

1 reference

22 June 2018

A Ohta

3

1 reference

22 June 2018

M Sekimoto

4

1 reference

22 June 2018

M Sato

5

1 reference

22 June 2018

H Makuuchi

6

1 reference

22 June 2018

T Kawano

7

1 reference

22 June 2018

M Taniguchi

8

1 reference

22 June 2018

T Nishimura

9

1 reference

22 June 2018

publication date

1 August 1999

1 reference

22 June 2018

number of pages

4

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

22 June 2018

volume

90

1 reference

22 June 2018

issue

8

1 reference

22 June 2018

page(s)

801-804

1 reference

22 June 2018

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926145

Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926145

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926145

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926145

The instructive role of innate immunity in the acquired immune response

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926145

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926145

Homogenous junctional sequence of the V14+ T-cell antigen receptor alpha chain expanded in unprimed mice

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926145

Application of interleukin 12 to antitumor cytokine and gene therapy

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926145

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

13 August 2018

1 reference

12 December 2020

Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12

1 reference

12 December 2020

Protein kinase C required for cytotoxic T lymphocyte triggering

1 reference

12 December 2020

Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000

1 reference

12 December 2020

10.1111/J.1349-7006.1999.TB00818.X

Identifiers

DOI

1 reference

22 June 2018

PMCID

5926145

1 reference

22 June 2018

PubMed ID

10543249

1 reference

22 June 2018